GO:0035663 Toll-like receptor 2 binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035663 (Toll-like receptor 2 binding) is a molecular function describing the selective interaction of a protein or ligand with Toll-like receptor 2 (TLR2), a pattern recognition receptor that initiates innate immune signaling.
• TLR2 recognizes a broad range of microbial and endogenous ligands, often as heterodimers with TLR1 or TLR6, and this binding event is the first step in NF-kB-dependent inflammatory gene expression.
• The term is distinct from TLR2 signaling itself: it captures the binding step, which can be studied with recombinant TLR2 ectodomains, co-immunoprecipitation, and surface plasmon resonance.
• Dysregulated TLR2 binding contributes to diseases including critical illness, vitiligo, and intestinal inflammation, making it a target for experimental therapeutics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of TLR2-binding proteins and their downstream effects.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect TLR2-binding mechanisms in immunology and disease research.
Description
Toll-like receptor 2 binding (GO:0035663) is a molecular function that defines the physical interaction between a protein or ligand and Toll-like receptor 2 (TLR2), a cell-surface pattern recognition receptor of the innate immune system. TLR2 is unusual among Toll-like receptors because it forms heterodimers with TLR1 or TLR6 to recognize a wide array of microbial patterns, including lipoproteins and lipoteichoic acid, and it can also bind endogenous danger signals. The binding event itself is the molecular trigger that positions TLR2 for downstream signaling and inflammatory gene activation. For researchers, GO:0035663 provides a precise annotation for experiments that measure direct TLR2 engagement rather than downstream signaling. Assays such as surface plasmon resonance, co-immunoprecipitation, and recombinant ectodomain binding are used to assign this function to specific proteins and ligands. Because TLR2 binding is implicated in conditions ranging from critical illness to vitiligo and intestinal inflammation, understanding its molecular determinants has translational value. This article summarizes the authoritative GO definition, the biological and molecular context of TLR2 binding, the key genes and proteins involved, disease links, and the CRISPR-based research methods used to study this function.
Toll-like receptor 2 binding At A Glance
| GO ID | GO:0035663 |
|---|---|
| GO term | Toll-like receptor 2 binding |
| Ontology | Molecular function |
| Synonym | TLR2 binding |
| Definition | Binding to a Toll-like 2 protein, a pattern recognition receptor that binds microbial pattern motifs to initiate an innate immune response. |
| Major function | Direct physical interaction with TLR2, enabling ligand recognition and initiation of innate immune signaling. |
| Related receptors | TLR1, TLR6, and TLR2 heterodimers. |
| Representative ligands | Microbial lipoproteins, lipoteichoic acid, and endogenous danger signals. |
| Disease relevance | Critical illness, vitiligo, intestinal inflammation, and infection. |
What Is GO:0035663?
GO:0035663 (Toll-like receptor 2 binding) is defined by QuickGO as the binding to a Toll-like 2 protein, a pattern recognition receptor that binds microbial pattern motifs to initiate an innate immune response. In practice, this means any gene product or ligand that directly and selectively interacts with TLR2 qualifies for this annotation, whether the interaction occurs at the cell surface, in endosomes, or in recombinant binding assays.
Why Is Toll-like receptor 2 binding Important in Cell Biology?
TLR2 binding is important because it is the molecular gatekeeper for a major arm of innate immunity. The interaction between TLR2 and its ligands determines whether the receptor adopts an active conformation and recruits adaptor proteins, which in turn controls NF-kB and inflammatory cytokine production. Because TLR2 can bind both microbial and host-derived ligands, dysregulated TLR2 binding is linked to infectious, inflammatory, and autoimmune conditions. Studying this function at the binding step, rather than only downstream signaling, allows researchers to identify specific agonists, antagonists, and host factors that modulate innate immune activation.
• TLR2 binding initiates innate immune responses to bacterial lipoproteins and other microbial patterns.
• TLR2 heterodimerization with TLR1 or TLR6 expands ligand specificity and is a key determinant of binding.
• TLR2 binding on circulating neutrophils is associated with increased mortality in critically ill patients.
• Heat shock protein 70 binding to TLR2 contributes to melanocyte ferroptosis in vitiligo onset.
• Dietary fiber pectin can directly block TLR2-1 binding and prevent doxorubicin-induced ileitis.
• TLR2 stimulation can augment esophageal barrier integrity, showing context-dependent protective roles.
• Volatile anesthetics such as sevoflurane attenuate TLR1/2 activation, linking binding to pharmacological modulation.
• TLR2 binding is a target for anti-inflammatory drug discovery and for vaccine adjuvant design.
• CRISPR models enable causal testing of TLR2-binding proteins in immune and epithelial cells.
• Understanding TLR2 binding helps explain inter-individual differences in infection and inflammation outcomes.
Molecular Mechanism of Toll-like receptor 2 binding
Ligand recognition by TLR2 heterodimers
In simple terms: TLR2 does not work alone; it pairs with TLR1 or TLR6 to grab different microbial molecules.
TLR2 forms heterodimers with TLR1 or TLR6 at the cell surface, and the binding pocket is formed at the interface of the two receptors. This heterodimerization is required for recognition of triacylated and diacylated lipopeptides, respectively, and determines which ligands can bind. The binding event stabilizes the receptor ectodomain and positions the intracellular TIR domains for downstream signaling.
Binding affinity and specificity determinants
In simple terms: Small differences in the ligand or the receptor pocket change how tightly TLR2 binds.
Specific activators of the human TLR2/6 heterodimer, such as mono-palmitoyl-N-alkylurea ligands, demonstrate that chemical structure controls binding specificity. Zinc ions can modulate the structure and activity of the TLR1 intracellular domain, indicating that cofactors influence receptor conformation and binding competence. These findings show that TLR2 binding is not a simple on/off switch but is tuned by ligand chemistry and receptor microenvironment.
Endogenous and dietary modulators of TLR2 binding
In simple terms: Host molecules and even food components can block or mimic TLR2 ligands.
Dietary fiber pectin directly blocks TLR2-1 binding and prevents doxorubicin-induced ileitis, showing that non-microbial molecules can occupy the TLR2 binding site. Heat shock protein 70 can bind TLR2 and orchestrate melanocyte ferroptosis in vitiligo, illustrating an endogenous ligand with pathological consequences. These examples expand the functional repertoire of GO:0035663 beyond microbial pattern recognition.
Pharmacological and anesthetic modulation
In simple terms: Some drugs can weaken TLR2 binding and reduce inflammation.
Volatile anesthetic sevoflurane attenuates TLR1/2 activation, providing evidence that small molecules can interfere with TLR2 binding or its immediate consequences. Such pharmacological modulation is relevant for perioperative inflammation and for developing TLR2-targeted therapeutics.
Consequences of TLR2 binding for cellular signaling
In simple terms: Once TLR2 binds a ligand, it switches on inflammatory signals inside the cell.
Ligand binding to TLR2 recruits adaptor proteins and triggers signaling cascades that activate NF-kB and MAP kinases, leading to cytokine and chemokine expression. In neutrophils, TLR2 expression and binding correlate with clinical outcomes in critically ill patients, linking the molecular function to systemic inflammation. In esophageal epithelium, TLR2 stimulation can augment barrier integrity, showing that downstream outcomes are cell-type specific.
Key Genes Involved in GO:0035663 Toll-like receptor 2 binding
The following genes and proteins are directly or functionally linked to Toll-like receptor 2 binding (GO:0035663) based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR2 | Pattern recognition receptor that binds microbial and endogenous ligands | Core receptor for GO:0035663; knockout and point-mutation models test ligand binding and signaling. |
| TLR1 | Forms heterodimers with TLR2 for triacylated lipoprotein recognition | Modulates TLR2 binding specificity; intracellular domain structure is regulated by Zn2+. |
| TLR6 | Forms heterodimers with TLR2 for diacylated lipoprotein recognition | Target for specific activators such as mono-palmitoyl-N-alkylurea ligands. |
| HSP70 | Endogenous chaperone that can bind TLR2 | Drives melanocyte ferroptosis in vitiligo via TLR2 binding. |
| MYD88 | Adaptor protein recruited after TLR2 binding | Downstream signaling node; not a direct binder but essential for TLR2 responses. |
| NFKB1 | Transcription factor activated downstream of TLR2 binding | Readout of TLR2-dependent inflammatory gene expression. |
| TNF | Pro-inflammatory cytokine induced by TLR2 signaling | Biomarker of TLR2 activation in immune and epithelial cells. |
| IL6 | Cytokine induced by TLR2 binding and signaling | Common readout in TLR2 stimulation experiments. |
| IL8 | Chemokine induced by TLR2 activation | Used to measure TLR2-dependent neutrophil recruitment. |
| Pectin (dietary fiber) | Non-microbial blocker of TLR2-1 binding | Prevents doxorubicin-induced ileitis in experimental models. |
| Sevoflurane | Volatile anesthetic that attenuates TLR1/2 activation | Pharmacological tool to probe TLR2 binding consequences. |
| Zn2+ | Ion that modulates TLR1 intracellular domain structure | Cofactor influencing TLR2 heterodimer function. |
| CD14 | Co-receptor that facilitates ligand presentation to TLR2 | Enhances TLR2 binding efficiency in some cell types. |
| LY96 (MD-2) | Accessory protein for TLR4, not TLR2 | Included as a contrast for TLR2-specific binding studies. |
| TIRAP | Adaptor that bridges TLR2 to MYD88 | Downstream of binding; relevant for signaling assays. |
| IRAK4 | Kinase activated after TLR2 binding | Signaling readout; not a direct binder. |
| TRAF6 | E3 ubiquitin ligase downstream of TLR2 | Amplifies inflammatory signaling after binding. |
How Is Toll-like receptor 2 binding Regulated?
TLR2 binding is regulated at multiple levels. Heterodimerization with TLR1 or TLR6 determines ligand specificity and binding competence. Cofactors such as Zn2+ can modulate the structure of the TLR1 intracellular domain, indirectly affecting the receptor complex. Pharmacological agents like sevoflurane can attenuate TLR1/2 activation, suggesting that binding or its immediate consequences are druggable. Endogenous ligands such as HSP70 and dietary components like pectin can compete with or block microbial ligand binding, providing additional regulatory layers. Expression levels of TLR2 on circulating neutrophils also correlate with clinical outcomes, indicating that receptor abundance influences the overall binding capacity.
Toll-like receptor 2 binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR2 | Critical illness and increased mortality | TLR2 knockout neutrophils or patient-derived cells. |
| HSP70 | Vitiligo and melanocyte ferroptosis | HSP70 overexpression or knockout in melanocytes. |
| TLR2/TLR1 | Doxorubicin-induced ileitis | Intestinal epithelial TLR2-1 blocking assays with pectin. |
| TLR2 | Esophageal barrier dysfunction | TLR2 stimulation in esophageal epithelial cells. |
| TLR1/TLR2 | Perioperative inflammation | Sevoflurane treatment in TLR1/2 activation assays. |
TLR2 binding in critical illness and infection
TLR2 and TLR9 expression on circulating neutrophils is associated with increased mortality in critically ill patients, suggesting that TLR2 binding capacity contributes to systemic inflammation and poor outcomes. In this context, measuring TLR2 binding and downstream signaling may help stratify patients or guide anti-inflammatory strategies.
TLR2 binding in vitiligo and melanocyte ferroptosis
Heat shock protein 70 binding to TLR2 orchestrates melanocyte ferroptosis in the onset of vitiligo, linking an endogenous TLR2 ligand to autoimmune pigment loss. This positions GO:0035663 as a potential target for preventing melanocyte death in vitiligo.
TLR2 binding in intestinal inflammation
Dietary fiber pectin directly blocks TLR2-1 binding and prevents doxorubicin-induced ileitis, demonstrating that interfering with TLR2 binding can protect the intestinal barrier. Conversely, TLR2 stimulation can augment esophageal barrier integrity, highlighting context-dependent effects.
TLR2 binding as a pharmacological target
Volatile anesthetics such as sevoflurane attenuate TLR1/2 activation, and specific activators of TLR2/6 have been developed, showing that TLR2 binding is amenable to pharmacological modulation. These findings support drug discovery efforts targeting the TLR2 binding interface.
From Toll-like receptor 2 binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TLR2 bind a candidate ligand directly? | Recombinant TLR2 ectodomain binding assay or surface plasmon resonance. |
| Is TLR2 required for a cellular response? | TLR2 knockout cell line generated by CRISPR. |
| Does a point mutation in TLR2 alter ligand specificity? | CRISPR point-mutation knock-in of TLR2 variants. |
| Can a tagged TLR2 be used to pull down binding partners? | Knock-in of epitope-tagged TLR2. |
| Does overexpression of a candidate ligand increase TLR2 binding? | Overexpression cell model with TLR2 reporter. |
| Which genes modulate TLR2 binding in a genome-wide screen? | CRISPR library screening with TLR2-binding readout. |
How to Study the Toll-like receptor 2 binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Real-time binding affinity and kinetics | TLR2-ligand interaction studies. |
| Co-immunoprecipitation | Physical interaction in cell lysates | Identifying TLR2 binding partners. |
| ELISA | Cytokine production after TLR2 activation | Functional readout of TLR2 binding. |
| Luciferase reporter assay | NF-kB activation | Downstream signaling after TLR2 binding. |
| RNA-seq | Transcriptional changes | Global response to TLR2 ligands. |
| CRISPR knockout screening | Gene requirement for TLR2 binding | Identifying modulators of GO:0035663. |
| Flow cytometry | Cell surface TLR2 expression | Correlating expression with binding capacity. |
| Mass spectrometry | Protein composition of TLR2 complexes | Discovering novel binding partners. |
Binding assays for TLR2
Direct binding of proteins or ligands to TLR2 can be measured using surface plasmon resonance, isothermal titration calorimetry, or ELISA-based binding assays with recombinant TLR2 ectodomains. These methods assign GO:0035663 activity to specific molecules and quantify affinity.
Co-immunoprecipitation and pull-down
Co-immunoprecipitation of TLR2 with candidate partners from cell lysates, followed by mass spectrometry, identifies endogenous binding complexes. Tagged TLR2 knock-in models facilitate these experiments.
Cell-based signaling readouts
TLR2 binding leads to NF-kB activation and cytokine production, which can be measured by luciferase reporter assays, ELISA for IL-6 or TNF, or RNA-seq. These readouts confirm that binding is functional.
CRISPR screening and bioinformatics
Genome-wide CRISPR knockout or activation screens coupled with TLR2-binding readouts can identify modulators of this function. Bioinformatics analysis of transcriptomic and proteomic data helps prioritize candidate genes.
How CRISPR Can Be Used to Study GO:0035663 Toll-like receptor 2 binding
Knockout
CRISPR knockout of TLR2 or its heterodimer partners (TLR1, TLR6) eliminates binding and downstream signaling, providing a clean negative control for GO:0035663 assays. Knockout of candidate ligands such as HSP70 can test their contribution to TLR2-dependent phenotypes.
Point Mutation
Point mutations in the TLR2 ligand-binding pocket or in TLR1/6 interface residues can be introduced by CRISPR to test specificity determinants. Such models help distinguish binding from signaling defects.
Knock-in
Knock-in of epitope-tagged TLR2 or of disease-associated variants allows pull-down and imaging of TLR2 binding complexes in a physiological context. Tagged knock-in models are valuable for proteomic identification of binding partners.
Overexpression
Overexpression of TLR2 or candidate ligands can amplify binding signals for detection and can model pathological states such as vitiligo, where HSP70-TLR2 binding drives melanocyte ferroptosis. Overexpression models are also useful for screening antagonists.
How EDITGENE Supports Toll-like receptor 2 binding Research
Researchers studying Toll-like receptor 2 binding-related genes often need to determine whether a candidate gene is causally involved in ligand recognition, receptor activation, or downstream inflammation. EDITGENE provides validated CRISPR cell models and screening services to test these hypotheses with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for Toll-like receptor 2 binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TIRAP Knockout HEK293 Cell Line | EDJ-KQ594 | Human | 114609 | Details Get a Quote |
| TLR6 Knockout HEK293 Cell Line | EDJ-KQ7010 | Human | 10333 | Details Get a Quote |
| TLR10 Knockout HEK293 Cell Line | EDJ-KQ9746 | Human | 81793 | Details Get a Quote |
| TLR1 Knockout HEK293 Cell Line | EDJ-KQ15744 | Human | 7096 | Details Get a Quote |
| TIRAP Knockout A-549 Cell Line | EDJ-KQ19032 | Human | 114609 | Details Get a Quote |
| TIRAP Knockout HCT 116 Cell Line | EDJ-KQ19033 | Human | 114609 | Details Get a Quote |
| TIRAP Knockout HeLa Cell Line | EDJ-KQ19034 | Human | 114609 | Details Get a Quote |
| TLR6 Knockout HCT 116 Cell Line | EDJ-KQ30372 | Human | 10333 | Details Get a Quote |
| TLR6 Knockout A-549 Cell Line | EDJ-KQ31747 | Human | 10333 | Details Get a Quote |
| TLR6 Knockout HeLa Cell Line | EDJ-KQ31748 | Human | 10333 | Details Get a Quote |
| TLR1 Knockout HCT 116 Cell Line | EDJ-KQ45440 | Human | 7096 | Details Get a Quote |
| TLR1 Knockout A-549 Cell Line | EDJ-KQ46667 | Human | 7096 | Details Get a Quote |
| TLR1 Knockout THP-1 Cell Line | EDJ-KZ509 | Human | 7096 | Details Get a Quote |
| TLR1 Knockout HeLa Cell Line | EDJ-KQ54665 | Human | 7096 | Details Get a Quote |
| TLR10 Knockout HeLa Cell Line | EDJ-KQ57413 | Human | 81793 | Details Get a Quote |
Displaying Records 1 To 15 Of 17 Records
Frequently Asked Questions About Toll-like receptor 2 binding
What is GO:0035663?
GO:0035663 is the Gene Ontology molecular function term for Toll-like receptor 2 binding, defined as binding to a Toll-like 2 protein, a pattern recognition receptor that initiates innate immune responses.
What genes are involved in Toll-like receptor 2 binding?
Key genes include TLR2, TLR1, TLR6, HSP70, MYD88, and downstream effectors such as NFKB1 and TNF.
What does TLR2 binding do?
TLR2 binding triggers receptor activation, adaptor recruitment, and NF-kB-dependent inflammatory gene expression.
How is TLR2 binding measured?
Common methods include surface plasmon resonance, co-immunoprecipitation, ELISA, and luciferase reporter assays.
Is TLR2 binding involved in disease?
Yes, it is implicated in critical illness, vitiligo, intestinal inflammation, and perioperative inflammation.
What ligands bind TLR2?
Microbial lipoproteins, lipoteichoic acid, endogenous HSP70, and dietary pectin can interact with TLR2 or its heterodimers.
Can CRISPR be used to study TLR2 binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test TLR2 binding mechanisms.
What is the difference between TLR2 binding and TLR2 signaling?
Binding is the physical interaction with TLR2, while signaling refers to downstream events such as NF-kB activation after binding.
Which diseases are linked to TLR2 binding?
Critical illness mortality, vitiligo, doxorubicin-induced ileitis, and esophageal barrier dysfunction have been linked to TLR2 binding.
How can I study TLR2 binding in my lab?
You can use recombinant binding assays, CRISPR cell models, and bioinformatics; EDITGENE offers end-to-end services for these approaches.
Conclusion
GO:0035663 (Toll-like receptor 2 binding) captures a central molecular event in innate immunity: the direct interaction of ligands or proteins with TLR2. This function is essential for microbial recognition, inflammatory signaling, and host defense, and its dysregulation contributes to diseases ranging from critical illness to vitiligo and intestinal inflammation. By combining precise binding assays with CRISPR knockout, point-mutation, knock-in, and overexpression models, researchers can dissect the molecular determinants of TLR2 binding and translate these insights into therapeutic strategies. EDITGENE supports these efforts with validated cell models and screening services.
References
- 1. Ruffner MA et al.. 2019. Toll-like receptor 2 stimulation augments esophageal barrier integrity.. Allergy 74(12):2449-2460 PMID: 31267532
- 2. Xing X et al.. 2026. Heat shock protein 70/toll-like receptor 2 orchestrates melanocyte ferroptosis in the onset of vitiligo.. J Invest Dermatol 146(7):1966-1977.e7 PMID: 41544889
- 3. Lushpa VA et al.. 2021. Modulation of Toll-like receptor 1 intracellular domain structure and activity by Zn(2+) ions.. Commun Biol 4(1):1003 PMID: 34429510
- 4. Mitsui Y et al.. 2020. Volatile Anesthetic Sevoflurane Attenuates Toll-Like Receptor 1/2 Activation.. Anesth Analg 131(2):631-639 PMID: 32149756
- 5. Isendoorn MME et al.. 2024. Mono-Palmitoyl-N-Alkylurea Ligands as Specific Activators of Human Toll-Like Receptor 2/6 Heterodimer.. Chembiochem 25(23):e202400583 PMID: 39381901
- 6. Lenz M et al.. 2020. Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients.. Shock 54(1):35-43 PMID: 31688663
- 7. Yang RB et al.. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.. Nature 395(6699):284-8 PMID: 9751057
- 8. Sahasrabudhe NM et al.. 2018. Dietary Fiber Pectin Directly Blocks Toll-Like Receptor 2-1 and Prevents Doxorubicin-Induced Ileitis.. Front Immunol 9:383 PMID: 29545800
